- Home
- Publications
- Publication Search
- Publication Details
Title
Immune therapy in type 1 diabetes mellitus
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume 9, Issue 2, Pages 92-103
Publisher
Springer Nature
Online
2013-01-09
DOI
10.1038/nrendo.2012.237
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Through the Fog: Recent Clinical Trials to Preserve -Cell Function in Type 1 Diabetes
- (2012) C. J. Greenbaum et al. DIABETES
- Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs -Cell Function
- (2012) S. A. Long et al. DIABETES
- B-Cell Cross-Presentation of Autologous Antigen Precipitates Diabetes
- (2012) E. Marino et al. DIABETES
- GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus
- (2012) Johnny Ludvigsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes
- (2012) Denise L. Faustman et al. PLoS One
- Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin-dependent diabetes mellitus in the Genetically at Risk (TRIGR)
- (2011) et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes
- (2011) C. Andersson et al. AUTOIMMUNITY
- T Cell Recognition of Autoantigens in Human Type 1 Diabetes: Clinical Perspectives
- (2011) Roberto Mallone et al. Clinical & Developmental Immunology
- Rituximab Selectively Suppresses Specific Islet Antibodies
- (2011) L. Yu et al. DIABETES
- Maternal Serum Levels of 25-Hydroxy-Vitamin D During Pregnancy and Risk of Type 1 Diabetes in the Offspring
- (2011) I. M. Sorensen et al. DIABETES
- Impact of Intranasal Insulin on Insulin Antibody Affinity and Isotypes in Young Children With HLA-Conferred Susceptibility to Type 1 Diabetes
- (2011) S. J. Ryhanen et al. DIABETES CARE
- Long-Term Outcome of Individuals Treated With Oral Insulin: Diabetes Prevention Trial-Type 1 (DPT-1) oral insulin trial
- (2011) K. Vehik et al. DIABETES CARE
- Reduced Prevalence of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Young Children Participating in Longitudinal Follow-Up
- (2011) H. Elding Larsson et al. DIABETES CARE
- Primary Dietary Intervention Study to Reduce the Risk of Islet Autoimmunity in Children at Increased Risk for Type 1 Diabetes: The BABYDIET study
- (2011) S. Hummel et al. DIABETES CARE
- The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial
- (2011) Gerlies Bock et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Low risk HLA-DQ and increased body mass index in newly diagnosed type 1 diabetes children in the Better Diabetes Diagnosis study in Sweden
- (2011) A Carlsson et al. INTERNATIONAL JOURNAL OF OBESITY
- Effect of rituximab on human in vivo antibody immune responses
- (2011) Mark D. Pescovitz et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Vaccination against type 1 diabetes
- (2011) H. E. Larsson et al. JOURNAL OF INTERNAL MEDICINE
- Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
- (2011) Diane K Wherrett et al. LANCET
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
- (2011) Nicole Sherry et al. LANCET
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes
- (2011) Frank Waldron-Lynch et al. NATURE REVIEWS DRUG DISCOVERY
- The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants
- (2011) William A Hagopian et al. PEDIATRIC DIABETES
- Preliminary studies related to anti-interleukin-1β therapy in children with newly diagnosed type 1 diabetes
- (2011) Kathryn M. Sumpter et al. PEDIATRIC DIABETES
- Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes
- (2011) Stina Axelsson et al. PLoS One
- A historical view from thirty eventful years of immunotherapy in autoimmune diabetes
- (2011) Jean-François Bach et al. SEMINARS IN IMMUNOLOGY
- Failure to Preserve -Cell Function With Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients With New- Onset Type 1 Diabetes
- (2010) P. A. Gottlieb et al. DIABETES CARE
- Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass
- (2010) B. Keymeulen et al. DIABETOLOGIA
- β-cell function and metabolic control in latent autoimmune diabetes in adults with early insulin versus conventional treatment: a 3-year follow-up
- (2010) Maria Thunander et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Harmonization of Glutamic Acid Decarboxylase and Islet Antigen-2 Autoantibody Assays for National Institute of Diabetes and Digestive and Kidney Diseases Consortia
- (2010) Ezio Bonifacio et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dietary Intervention in Infancy and Later Signs of Beta-Cell Autoimmunity
- (2010) Mikael Knip et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years
- (2009) Kevan C. Herold et al. CLINICAL IMMUNOLOGY
- Monitoring of antigen-specific CD8 T cells in patients with type 1 diabetes treated with antiCD3 monoclonal antibodies
- (2009) Simona Cernea et al. CLINICAL IMMUNOLOGY
- No Effect of the Altered Peptide Ligand NBI-6024 on -Cell Residual Function and Insulin Needs in New-Onset Type 1 Diabetes
- (2009) M. Walter et al. DIABETES CARE
- Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1
- (2009) T. Orban et al. DIABETES CARE
- GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes
- (2009) C.-D. Agardh et al. DIABETOLOGIA
- Immunomodulation with heat shock protein DiaPep277 to preserve beta cell function in type 1 diabetes – an update
- (2009) Britta Fischer et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Genetics of Type 1A Diabetes
- (2009) Patrick Concannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modulating the natural history of type 1 diabetes in children at high genetic risk by mucosal insulin immunization
- (2008) Peter Achenbach et al. Current Diabetes Reports
- Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2
- (2008) C. Törn et al. DIABETOLOGIA
- Antigen presentation of detergent-free glutamate decarboxylase (GAD65) is affected by human serum albumin as carrier protein
- (2008) Jordan Steed et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
- (2008) Kirsti Näntö-Salonen et al. LANCET
- GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes
- (2008) Johnny Ludvigsson et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started